Researchers in the United States have conducted a study showing that Moderna's coronavirus disease 2019 (COVID-19) vaccine provided durable protection against the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ...
from Google Alert - health https://ift.tt/3mkpvh3
via IFTTT
0 comments:
Post a Comment